Accendra Health Posts $1.16 Q2 Loss Per Share, Deepening Red Ink
ACH sits 47% above its 52-week low of $1.84.
Summary
Accendra Health reported a Q2 loss of $1.16 per share, missing estimates and deepening its financial strain. The company also missed revenue estimates, attributing the shortfall to a large payor exit. The loss is highly material relative to its $214 million market cap and $2.70 share price. The company recently completed a major debt restructuring, but operational challenges persist. Leadership uncertainty looms with the CEO's planned retirement by year-end, and a $200M shelf registration filed in July signals potential dilution ahead.
At the time of this announcement, ACH was trading at $2.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $214.4M. The 52-week trading range was $1.84 to $7.10. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.